Daclizumab - Oncidium Foundation

Google:

CONTACT

ABOUT
- Our Team
PATIENT SUPPORT
THERAPY CENTERS
- Find a Treatment Center
- Register Your Hospital
EDUCATION
MEDIA
GET INVOLVED
DONATE
Search for:

ABOUT
- Our Team
PATIENT SUPPORT
THERAPY CENTERS
- Find a Treatment Center
- Register Your Hospital
EDUCATION
MEDIA
GET INVOLVED
DONATE

Search for:

31239

Y-90-Daclizumab (HAT)
Gallery
Y-90-Daclizumab (HAT)

Y-90-Daclizumab (HAT)

90Y-labeled humanized anti-Tac (90Y-HAT, 90Y-Daclizumab) is a radiolabeled monoclonal antibody [...]

support dev2022-04-21T13:25:41+00:00

About
Newsroom
Contact

Page load link

This website uses cookies and other tracking technologies to improve your browsing experience, analyze site traffic, and understand where our audience is coming from. To find out more, please read our Privacy Policy, which has been updated and became effective December 1, 2019.

ACCEPT REJECT
Privacy Policy Disclaimer

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

SAVE & ACCEPT

Go to Top